RE:KOLwhy wouldn't they. grant AA Venture ??
WEll they need evidence of a surrogate end-point biomarker... I'm hoping that the increased PFS will act as a surrogate for increased OS, thereby allowing ONCY to go for approval on the basis of PFS.
but the data needs to mature for that to happen, otherwise, they will need OS as end point, which will take 3-4 years... :-(